Hims & Hers Health, Inc. (NYSE:HIMS) Shares Acquired by Principal Financial Group Inc.

Principal Financial Group Inc. raised its holdings in shares of Hims & Hers Health, Inc. (NYSE:HIMSFree Report) by 17.9% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 16,655 shares of the company’s stock after purchasing an additional 2,525 shares during the quarter. Principal Financial Group Inc.’s holdings in Hims & Hers Health were worth $258,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Belpointe Asset Management LLC raised its holdings in Hims & Hers Health by 10.0% in the fourth quarter. Belpointe Asset Management LLC now owns 13,238 shares of the company’s stock valued at $118,000 after acquiring an additional 1,205 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of Hims & Hers Health by 5.6% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 29,335 shares of the company’s stock worth $261,000 after purchasing an additional 1,561 shares during the last quarter. Baldwin Brothers LLC MA grew its stake in Hims & Hers Health by 17.0% in the fourth quarter. Baldwin Brothers LLC MA now owns 22,128 shares of the company’s stock worth $197,000 after purchasing an additional 3,215 shares in the last quarter. Victory Capital Management Inc. grew its stake in Hims & Hers Health by 23.0% in the fourth quarter. Victory Capital Management Inc. now owns 18,348 shares of the company’s stock worth $163,000 after purchasing an additional 3,429 shares in the last quarter. Finally, QRG Capital Management Inc. raised its stake in Hims & Hers Health by 20.0% during the fourth quarter. QRG Capital Management Inc. now owns 27,712 shares of the company’s stock valued at $247,000 after buying an additional 4,616 shares in the last quarter. 63.52% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research analysts have recently commented on HIMS shares. Piper Sandler lifted their target price on Hims & Hers Health from $11.00 to $13.00 and gave the stock a “neutral” rating in a research report on Tuesday, May 7th. Canaccord Genuity Group began coverage on shares of Hims & Hers Health in a research note on Wednesday, April 10th. They set a “buy” rating and a $20.00 target price for the company. Bank of America raised their price target on shares of Hims & Hers Health from $22.00 to $26.00 and gave the stock a “buy” rating in a research report on Thursday, June 13th. Citigroup downgraded shares of Hims & Hers Health from a “buy” rating to a “neutral” rating and boosted their price objective for the company from $16.00 to $20.00 in a research report on Wednesday, May 22nd. Finally, Seaport Res Ptn reissued a “buy” rating on shares of Hims & Hers Health in a report on Friday, April 26th. Seven analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $17.00.

View Our Latest Research Report on HIMS

Hims & Hers Health Stock Performance

Shares of NYSE HIMS opened at $20.78 on Monday. The firm’s 50-day simple moving average is $18.45 and its 200 day simple moving average is $13.99. Hims & Hers Health, Inc. has a fifty-two week low of $5.65 and a fifty-two week high of $25.74.

Hims & Hers Health (NYSE:HIMSGet Free Report) last issued its quarterly earnings results on Monday, May 6th. The company reported $0.05 earnings per share for the quarter, topping analysts’ consensus estimates of $0.02 by $0.03. Hims & Hers Health had a negative net margin of 0.24% and a negative return on equity of 0.70%. The company had revenue of $278.20 million during the quarter, compared to analyst estimates of $270.37 million. During the same period in the prior year, the business posted ($0.05) EPS. The business’s revenue for the quarter was up 45.8% compared to the same quarter last year. On average, sell-side analysts expect that Hims & Hers Health, Inc. will post 0.2 EPS for the current fiscal year.

Insider Activity

In other news, insider Soleil Boughton sold 2,503 shares of the company’s stock in a transaction on Monday, April 15th. The stock was sold at an average price of $13.95, for a total value of $34,916.85. Following the completion of the sale, the insider now owns 164,363 shares in the company, valued at $2,292,863.85. The sale was disclosed in a legal filing with the SEC, which is available at this link. In other Hims & Hers Health news, CEO Andrew Dudum sold 188,888 shares of Hims & Hers Health stock in a transaction that occurred on Wednesday, May 1st. The shares were sold at an average price of $12.54, for a total value of $2,368,655.52. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Soleil Boughton sold 2,503 shares of the company’s stock in a transaction on Monday, April 15th. The shares were sold at an average price of $13.95, for a total value of $34,916.85. Following the completion of the transaction, the insider now directly owns 164,363 shares in the company, valued at approximately $2,292,863.85. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 747,898 shares of company stock worth $13,719,360. 17.71% of the stock is owned by company insiders.

Hims & Hers Health Company Profile

(Free Report)

Hims & Hers Health, Inc operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.

Featured Articles

Institutional Ownership by Quarter for Hims & Hers Health (NYSE:HIMS)

Receive News & Ratings for Hims & Hers Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hims & Hers Health and related companies with MarketBeat.com's FREE daily email newsletter.